The decentralized research organization Care Access Research has teamed up with AstraZeneca to support the Phase III clinical trial for AZD7442, AstraZeneca’s long-acting monoclonal antibody combination for the potential prevention of COVID-19.
Using Care Access’s Mobile Sites On Demand, the two will develop, deploy and manage clinical research sites across the country to assess the safety and...
